Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.41B |
| 2 |
American Tower
AMT
|
+$272M |
| 3 |
Microsoft
MSFT
|
+$271M |
| 4 |
Zoom
ZM
|
+$245M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.25% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.05% |
| 4 | Consumer Discretionary | 12.39% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Patrick Industries
PATK
$2.77B
| $23.3M | ﹤0.01% |
511,698
+19,396
| +4% | +$822K |
|
|
BIG
1627
DELISTED
Big Lots, Inc.
BIG
| $23.3M | ﹤0.01% |
542,722
+20,674
| +4% | +$1M |
|
|
AAWW
1628
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $23.3M | ﹤0.01% |
427,127
+24,466
| +6% | +$1.44M |
|
1629
Ligand Pharmaceuticals
LGND
$5.85B
| $23.3M | ﹤0.01% |
374,793
+3,160
| +0.9% | +$180K |
|
1630
Virtu Financial
VIRT
$5.12B
| $23.2M | ﹤0.01% |
921,723
+27,804
| +3% | +$644K |
|
|
ODP
1631
DELISTED
ODP
ODP
| $23.1M | ﹤0.01% |
788,956
-9,990
| -1% | -$253K |
|
1632
Gray Television
GTN
$434M
| $23.1M | ﹤0.01% |
1,288,826
+38,627
| +3% | +$612K |
|
1633
Health Catalyst
HCAT
$163M
| $23M | ﹤0.01% |
529,435
+42,866
| +9% | +$1.58M |
|
|
VRTU
1634
DELISTED
Virtusa Corporation
VRTU
| $23M | ﹤0.01% |
450,728
+20,900
| +5% | +$1.05M |
|
1635
Newmark Group
NMRK
$2.72B
| $23M | ﹤0.01% |
3,155,887
+493,842
| +19% | +$3.05M |
|
|
KAMN
1636
DELISTED
Kaman Corp
KAMN
| $22.9M | ﹤0.01% |
401,127
+7,186
| +2% | +$353K |
|
|
CVA
1637
DELISTED
Covanta Holding Corporation
CVA
| $22.9M | ﹤0.01% |
1,743,901
+82,163
| +5% | +$889K |
|
|
MRSN
1638
DELISTED
Mersana Therapeutics
MRSN
| $22.9M | ﹤0.01% |
34,372
+1,213
| +4% | +$675K |
|
1639
Westamerica Bancorp
WABC
$1.39B
| $22.9M | ﹤0.01% |
413,368
+15,514
| +4% | +$855K |
|
1640
Pennant Group
PNTG
$1.4B
| $22.8M | ﹤0.01% |
393,269
+13,626
| +4% | +$655K |
|
|
DRNA
1641
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $22.8M | ﹤0.01% |
1,032,838
+88,359
| +9% | +$1.95M |
|
1642
US Physical Therapy
USPH
$1.18B
| $22.8M | ﹤0.01% |
189,203
+64
| +0% | +$6.46K |
|
|
FOCS
1643
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $22.7M | ﹤0.01% |
522,149
+36,725
| +8% | +$1.47M |
|
1644
Cal-Maine
CALM
$4.08B
| $22.6M | ﹤0.01% |
603,048
+37,433
| +7% | +$1.44M |
|
1645
Myriad Genetics
MYGN
$285M
| $22.6M | ﹤0.01% |
1,143,966
+21,092
| +2% | +$341K |
|
1646
Ocular Therapeutix
OCUL
$1.84B
| $22.6M | ﹤0.01% |
1,090,351
+204,445
| +23% | +$3.04M |
|
|
ADAM
1647
Adamas Trust
ADAM
$848M
| $22.5M | ﹤0.01% |
1,522,246
+150,373
| +11% | +$1.9M |
|
1648
Park National Corp
PRK
$3.75B
| $22.4M | ﹤0.01% |
213,074
+6,750
| +3% | +$663K |
|
1649
Inovio Pharmaceuticals
INO
$57.3M
| $22.3M | ﹤0.01% |
210,367
+10,746
| +5% | +$1.43M |
|
1650
Sinclair Inc
SBGI
$1B
| $22.3M | ﹤0.01% |
701,036
+24,239
| +4% | +$579K |
|
Similar funds
Geode Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Geode Capital Management held 4,369 positions worth $596B, up 17% from $510B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q4 2020 filing shows 215 new, 3,067 increased, 650 reduced and 100 closed positions. Its largest new stake was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M. The largest sale was Tiffany & Co., an estimated $206M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,223,585 shares worth $85.4M.
- Geode Capital Management added most to Tesla in Q4 2020, an estimated $2.41B increase.
- Geode Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $131M.
- Geode Capital Management fully exited Tiffany & Co. in Q4 2020, selling an estimated $206M.
- Geode Capital Management's ten largest holdings make up 22% of its $596B portfolio in Q4 2020.
- Geode Capital Management opened 215 new positions and closed 100 in Q4 2020.
- Geode Capital Management's portfolio value rose 17% quarter-over-quarter to $596B.
Based on Geode Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.